We’re pleased to announce the publication of notice NOT-GM-23-040 introducing a change in the institutional eligibility criteria for applications to our Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20).
Continue reading “Notice of COBRE Phase 1 Change in Institutional Eligibility”Tag: Research Capacity Building
IDeA Networks of Biomedical Research Excellence Funding Opportunity and Upcoming Webinar
UPDATE: The webinar slides [PDF] and video are now available.
We’re pleased to announce that the IDeA Networks of Biomedical Research Excellence (INBRE) funding opportunity announcement (FOA) (PAR-23-100) has been issued. INBRE funds one statewide network of higher education and research institutions in each Institutional Development Award (IDeA)-eligible state and Puerto Rico to build biomedical research capacity through supporting faculty research and mentoring, student participation in research, and infrastructure enhancements at network institutions.
Application due date: June 26, 2023
Earliest start date: April 2024
Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar
UPDATE: The webinar slides [PDF] and video are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-23-063) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Application receipt date: May 29, 2023
Earliest start date: April 2024
COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar
UPDATE: The webinar slides [PDF] and video are now available.
We’re pleased to announce that we’ve published two notices of special interest (NOSIs) requesting applications to PAR-22-250, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), to build research capacity in data sciences (NOT-GM-23-011) and women’s health (NOT-GM-23-012) in IDeA states.
These NOSIs highlight the Office of Data Science Strategy’s interest in supporting meritorious applications on data science relevant to biomedical research, and the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health.
Continue reading “COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar”Centers of Biomedical Research Excellence (COBRE) Phase 1 Funding Opportunity and Upcoming Webinar
UPDATE: The slides [PDF] and video from this webinar are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 1 funding opportunity announcement (FOA) (PAR-22-250) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to establish a center of excellence that helps develop a critical mass of investigators and improve infrastructure in an area of biomedical research.
Application receipt date: January 30, 2023
Earliest start date: December 2023
Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar
UPDATE: The slides [PDF] and video for this webinar are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-22-163) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar”Webinar for COBRE Program Applicants and Grantees
UPDATE: The video and slides [PDF] from this webinar are now available.
If you’re planning to apply for a Phase 1, 2, or 3 Centers of Biomedical Research Excellence (COBRE) grant, it’s important that you attend our upcoming webinar:
Wednesday, October 27, 3:00-4:30 p.m. ET
During the webinar, we’ll present an overview of the COBRE program’s objectives, eligibility and reporting requirements, and other key aspects of the funding opportunity announcements. We’ll also answer any questions that you have.
Continue reading “Webinar for COBRE Program Applicants and Grantees”Funding Opportunities: COBRE Phase 1 Applications for Women’s Health and Data Sciences Research
We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).
These NOSIs highlight the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.
Continue reading “Funding Opportunities: COBRE Phase 1 Applications for Women’s Health and Data Sciences Research”Funding Opportunity: Urgent Competitive Revisions to IDeA-CTR Awards to Address the Continuing Need for Documenting COVID-19-Related Patient Outcomes
We’re pleased to announce a new notice of special interest (NOSI) (NOT-GM-21-050) to address the urgent need for documenting COVID-19-related outcomes of patients, including those suffering from health disparities, which helps foster COVID-19-related clinical research. Competitive revisions to active IDeA-CTR (U54) awards will be considered for the purpose of sustaining and strengthening the IDeA state COVID-19 patient registry, a component of the National COVID Cohort Collaborative.
Applications are due by June 18, 2021. If you have any questions about this NOSI, please contact Hongwei Gao.
Administrative Supplements for Institutional Development Awards
We’re pleased to announce the availability of administrative supplements to the Institutional Development Awards (IDeA). We invite eligible investigators to submit proposals in response to the following notices:
Continue reading “Administrative Supplements for Institutional Development Awards”